The microtubule-associated protein Tau and its relevance for pancreatic beta cells

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Maj, Magdalena ^a   Hoermann, Gregor ^a   Rasul, Sazan ^a   Base, Wolfgang ^a   Wagner, Ludwig ^a   Attems, Johannes ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; MICROTUBULE ASSOCIATED PROTEIN 2; MICROTUBULE ASSOCIATED PROTEIN 4; MOLECULAR MOTOR; PHOSPHATIDYLINOSITOL 3 KINASE; TAU PROTEIN; WORTMANNIN; ISOPROTEIN; MAPT PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; GENE OVEREXPRESSION; GROWTH RATE; HUMAN; HUMAN TISSUE; INSULIN RELEASE; INSULINOMA; INSULINOMA CELL LINE; LANGERHANS CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TRANSIENT TRANSFECTION; TRANSLATION REGULATION; UPREGULATION; ANIMAL; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOLECULAR CLONING; PANCREAS TUMOR; PATHOLOGY; PHOSPHORYLATION; PROTEIN TRANSPORT; RNA INTERFERENCE; SECRETION (PROCESS); TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CLONING, MOLECULAR; HUMANS; INSULIN; INSULIN-SECRETING CELLS; INSULINOMA; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN TRANSPORT; RATS; RNA INTERFERENCE; TAU PROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84957061064     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/1964634     Document Type: Article

References (62)

1. E. Batcher, P. Madaj, and A. G. Gianoukakis, "Pancreatic neuroendocrine tumors," Endocrine Research, vol. 36, no. 1, pp. 35-43, 2011.
2. Y. Jiao, C. Shi, B. H. Edil et al. , "DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors," Science, vol. 331, no. 6021, pp. 1199-1203, 2011.
3. D. Vaidakis, J. Karoubalis, T. Pappa, G. Piaditis, and G. N. Zografos, "Pancreatic insulinoma: current issues and trends," Hepatobiliary and Pancreatic Diseases International, vol. 9, no. 3, pp. 234-241, 2010.
4. D. W. Cleveland, "Microtubule MAPping," Cell, vol. 60, no. 5, pp. 701-702, 1990.
5. K. Tokuraku, M. Katsuki, T. Matui, T. Kuroya, and S. Kotani, "Microtubule-binding property of microtubule-associated protein differs from that of microtubule-associated protein 4 and tau," European Journal of Biochemistry, vol. 264, no. 3, pp. 996-1001, 1999.
6. D. W. Cleveland, S.-Y. Hwo, and M. W. Kirschner, "Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin," Journal of Molecular Biology, vol. 116, no. 2, pp. 207-225, 1977.
7. D. G. Drubin and M. W. Kirschner, "Tau protein function in living cells, The Journal of Cell Biology, vol. 103, no. 6, part 2, pp. 2739-2746, 1986.
8. A. Caceres and K. S. Kosik, "Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons," Nature, vol. 343, no. 6257, pp. 461-463, 1990.
9. M. A. Schlager and C. C. Hoogenraad, "Basic mechanisms for recognition and transport of synaptic cargos," Molecular Brain, vol. 2, no. 1, article 25, 2009.
10. G. R. Brisson, F. Malaisse-Lagae, and W. J. Malaisse, "The stimulus-secretion coupling of glucose-induced insulin release. VII. A proposed site of action for adenosine-3, 5-cyclic monophosphate," The Journal of Clinical Investigation, vol. 51, no. 2, pp. 232-241, 1972.
11. W. J. Malaisse, F. Malaisse-Lagae, E. VanObberghen et al. , "Role of microtubules in the phasic pattern of insulin release," Annals of the New York Academy of Sciences, vol. 253, pp. 630-652, 1975.
12. E. Van Obberghen, G. Somers, G. Devis et al. , "Dynamics of insulin release and microtubular-microfilamentous system. VII. Do microfilaments provide the motive force for the translocation and extrusion of beta granules?" Diabetes, vol. 24, no. 10, pp. 892-901, 1975.
13. F. Malaisse-Lagae, M. Amherdt, M. Ravazzola et al. , "Role of microtubules in the synthesis, conversion, and release of (pro)insulin. A biochemical and radioautographic study in rat islets," The Journal of Clinical Investigation, vol. 63, no. 6, pp. 1284-1296, 1979.
14. S. L. Howell and M. Tyhurst, "The cytoskeleton and insulin secretion," Diabetes/Metabolism Reviews, vol. 2, no. 1-2, pp. 107-123, 1986.
15. P. Neuville, M. T. Vanier, L. Michalik, and J. F. Launay, "In situ localization with digoxigenin-labelled probes of tau-related mRNAs in the rat pancreas," The Histochemical Journal, vol. 27, no. 8, pp. 565-574, 1995.
16. J. Miklossy, K. Taddei, R. Martins et al. , "Alzheimer disease: curly fibers and tangles in organs other than brain," Journal of Neuropathology and Experimental Neurology, vol. 58, no. 8, pp. 803-814, 1999.
17. I. Grundke-Iqbal, K. Iqbal, and Y.-C. Tung, "Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology," Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 13, pp. 4913-4917, 1986.
18. C. Duyckaerts, B. Delatour, and M.-C. Potier, "Classification and basic pathology of Alzheimer disease," Acta Neuropathologica, vol. 118, no. 1, pp. 5-36, 2009.
19. J. Miklossy, H. Qing, A. Radenovic et al. , "Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes," Neurobiology of Aging, vol. 31, no. 9, pp. 1503-1515, 2010.
20. M. Maj, W. Gartner, A. Ilhan, D. Neziri, J. Attems, and L. Wagner, "Expression of TAU in insulin-secreting cells and its interaction with the calcium-binding protein secretagogin," Journal of Endocrinology, vol. 205, no. 1, pp. 25-36, 2010.
21. W. Montague and K. W. Taylor, "Islet-cell metabolism during insulin release. Effects of glucose, citrate, octanoate, tolbutamide, glucagon and theophylline," Biochemical Journal, vol. 115, no. 2, pp. 257-262, 1969.
22. H. Sando, J. Borg, and D. F. Steiner, "Studies on the secretion of newly synthesized proinsulin and insulin fromisolated rat islets of Langerhans, The Journal of Clinical Investigation, vol. 51, no. 6, pp. 1476-1485, 1972.
23. H. J. Hahn, H. Jahr, K. D. Kohnert, and H. Zuehlke, "Investigations on isolated islets of Langerhans in vitro. Influence of temperature changes during preparation on some parameters of insulin metabolism," Hormone Research, vol. 6, no. 3, pp. 169-176, 1975.
24. G. A. Praz, P. A. Halban, C. B. Wollheim, B. Blondel, A. J. Strauss, and A. E. Renold, "Regulation of immunoreactiveinsulin release from a rat cell line (RINm5F)," Biochemical Journal, vol. 210, no. 2, pp. 345-352, 1983.
25. S. Efrat, M. Leiser, M. Surana, M. Tal, D. Fusco-Demane, and N. Fleischer, "Murine insulinoma cell line with normal glucoseregulated insulin secretion," Diabetes, vol. 42, no. 6, pp. 901-907, 1993.
26. M. Skelin, M. Rupnik, and A. Cencic, "Pancreatic beta cell lines and their applications in diabetes mellitus research," ALTEX, vol. 27, no. 2, pp. 105-113, 2010.
27. M. Tiedge, M. Hohne, and S. Lenzen, "Insulin secretion, insulin content and glucose phosphorylation in RINm5F insulinoma cells after transfection with human GLUT2 glucose-transporter cDNA," Biochemical Journal, vol. 296, no. 1, pp. 113-118, 1993.
28. L. Orci, M. Ravazzola, M. Amherdt, O. Madsen, J.-D. Vassalli, and A. Perrelet, "Direct identification of prohormone conversion site in insulin-secreting cells," Cell, vol. 42, no. 2, pp. 671-681, 1985.
29. X. Zhu, L. Orci, R. Carroll, C. Norrbom, M. Ravazzola, and D. F. Steiner, "Severe block in processing of proinsulin to insulin accompanied by elevation of des-64, 65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 16, pp. 10299-10304, 2002.
30. M. J. Donelan, G. Morfini, R. Julyan et al. , "Ca2+-dependent dephosphorylation of kinesin heavy chain oβ-granules in pancreatic β-cells: implications for regulated β-granule transport and insulin exocytosis, The Journal of Biological Chemistry, vol. 277, no. 27, pp. 24232-24242, 2002.
31. J.-P. Brion, G. Trempdagger, and J.-N. Octavedagger, "Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimers disease," American Journal of Pathology, vol. 154, no. 1, pp. 255-270, 1999.
32. K. Spittaels, C. Van Den Haute, J. Van Dorpe et al. , "Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein," American Journal of Pathology, vol. 155, no. 6, pp. 2153-2165, 1999.
33. A. Probst, J. Gotz, K. H. Wiederhold et al. , "Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein," Acta Neuropathologica, vol. 99, no. 5, pp. 469-481, 2000.
34. P. McMillan, E. Korvatska, P. Poorkaj et al. , "Tau isoform regulation is region-and cell-specific in mouse brain," Journal of Comparative Neurology, vol. 511, no. 6, pp. 788-803, 2008.
35. G. Hoermann, S. Cerny-Reiterer, A. Perne et al. , "Identification of oncostatin M as a STAT5-dependent mediator of bone marrow remodeling in KIT D816V-positive systemic mastocytosis," The American Journal of Pathology, vol. 178, no. 5, pp. 2344-2356, 2011.
36. A. Ferreira, J. Busciglio, and A. Caceres, "Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: evidence for the involvement of the microtubule-associated proteins, MAP-1a, HMW-MAP2 and Tau," Developmental Brain Research, vol. 49, no. 2, pp. 215-228, 1989.
37. D. N. Drechsel, A. A. Hyman, M. H. Cobb, and M. W. Kirschner, "Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau," Molecular Biology of the Cell, vol. 3, no. 10, pp. 1141-1154, 1992.
38. M.-T. Vanier, P. Neuville, L. Michalik, and J.-F. Launay, "Expression of specific tau exons in normal and tumoral pancreatic acinar cells," Journal of Cell Science, vol. 111, part 10, pp. 1419-1432, 1998.
39. M. Goedert and R. Jakes, "Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization," The EMBO Journal, vol. 9, no. 13, pp. 4225-4230, 1990.
40. C. Janke, M. Holzer, J. Klose, and T. Arendt, "Distribution of isoforms of the microtubule-associated protein tau in grey and white matter areas of human brain: a two-dimensional gelelectrophoretic analysis," FEBS Letters, vol. 379, no. 3, pp. 222-226, 1996.
41. Q. Hua and R.-Q. He, "Tau could protect DNA double helix structure," Biochimica et Biophysica Acta-Proteins and Proteomics, vol. 1645, no. 2, pp. 205-211, 2003.
42. Q. Hua, R.-Q. He, N. Haque et al. , "Microtubule associated protein tau binds to double-stranded but not single-stranded DNA," Cellular and Molecular Life Sciences, vol. 60, no. 2, pp. 413-421, 2003.
43. L. Lavoie, C. J. Band, M. Kong, J. J. M. Bergeron, and B. I. Posner, "Regulation of glycogen synthase in rat hepatocytes. Evidence for multiple signaling pathways," The Journal of Biological Chemistry, vol. 274, no. 40, pp. 28279-28285, 1999.
44. B. Esmaeli-Azad, J. H. McCarty, and S. C. Feinstein, "Sense and antisense transfection analysis of tau function: tau influences net microtubule assembly, neurite outgrowth and neuritic stability," Journal of Cell Science, vol. 107, part 4, pp. 869-879, 1994.
45. M. Morishima-Kawashima, M. Hasegawa, K. Takio et al. , "Hyperphosphorylation of tau in PHF," Neurobiology of Aging, vol. 16, no. 3, pp. 365-371, 1995.
46. J. H. Su, G. Deng, and C. W. Cotman, "Transneuronal degeneration in the spread of Alzheimers disease pathology: immunohistochemical evidence for the transmission of tau hyperphosphorylation," Neurobiology of Disease, vol. 4, no. 5, pp. 365-375, 1997.
47. J. Eidenmuller, T. Fath, A. Hellwig, J. Reed, E. Sontag, and R. Brandt, "Structural and functional implications of tau hyperphosphorylation: information fromphosphorylationmimicking mutated tau proteins," Biochemistry, vol. 39, no. 43, pp. 13166-13175, 2000.
48. M. Onorato, P. Mulvihill, J. Connolly, P. Galloway, P. Whitehouse, and G. Perry, "Alteration of neuritic cytoarchitecture in Alzheimer disease," Progress in Clinical and Biological Research, vol. 317, pp. 781-789, 1989.
49. H. Braak, E. Braak, and M. Strothjohann, "Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat," Neuroscience Letters, vol. 171, no. 1-2, pp. 1-4, 1994.
50. K. Iqbal, A. D. C. Alonso, C.-X. Gong et al. , "Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles," Journal of Neural TransmissionSupplement, vol. 53, pp. 169-180, 1998.
51. L. Li and C. Holscher, "Common pathological processes in Alzheimer disease and type 2 diabetes: a review," Brain Research Reviews, vol. 56, no. 2, pp. 384-402, 2007.
52. W.-Q. Zhao and M. Townsend, "Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimers disease," Biochimica et Biophysica Acta, vol. 1792, no. 5, pp. 482-496, 2009.
53. J. Gotz, L. M. Ittner, and Y.-A. Lim, "Common features between diabetes mellitus and Alzheimers disease," Cellular and Molecular Life Sciences, vol. 66, no. 8, pp. 1321-1325, 2009.
54. H. J. Jung, S. S. Park, J. O. Mok, T. K. Lee, C. S. Park, and S. A. Park, "Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes," Experimental Neurology, vol. 228, no. 2, pp. 232-241, 2011.
55. S. Chen, K. Townsend, T. E. Goldberg, P. Davies, and C. Conejero-Goldberg, "MAPT isoforms: differential transcriptional profiles related to 3R and 4R splice variants," Journal of Alzheimers Disease, vol. 22, no. 4, pp. 1313-1329, 2010.
56. S. J. Adams, M. A. DeTure, M. McBride, D. W. Dickson, and L. Petrucelli, "Three repeat isoforms of tau inhibit assembly of four repeat tau filaments," PLoS ONE, vol. 5, no. 5, Article ID e10810, 2010.
57. F. Liu and C.-X. Gong, "Tau exon 10 alternative splicing and tauopathies," Molecular Neurodegeneration, vol. 3, no. 1, article 8, 2008.
58. D. A. Dewitt, J. A. Hurd, N. Fox et al. , "Peri-nuclear clustering of mitochondria is triggered during aluminum maltolate induced apoptosis," Journal of Alzheimers Disease, vol. 9, no. 2, pp. 195-205, 2006.
59. D. W. Dickson, "Neuropathology of non-Alzheimer degenerative disorders," International Journal of Clinical and Experimental Pathology, vol. 3, no. 1, pp. 1-23, 2009.
60. A. Ebneth, R. Godemann, K. Stamer et al. , "Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimers disease, The Journal of Cell Biology, vol. 143, no. 3, pp. 777-794, 1998.
61. P. Delobel, C. Mailliot, M. Hamdane et al. , "Stable-tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies," Annals of the New York Academy of Sciences, vol. 1010, pp. 623-634, 2003.
62. Y. Tatebayashi, N. Haque, Y.-C. Tung, K. Iqbal, and I. Grundke-Iqbal, "Role of tau phosphorylation by glycogen synthase kinase-3β in the regulation of organelle transport," Journal of Cell Science, vol. 117, no. 9, pp. 1653-1663, 2004.